11-47359855-G-A
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PVS1PM2PP3PP5_Moderate
The NM_003120.3(SPI1):c.328C>T(p.Gln110Ter) variant causes a stop gained, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003120.3 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPI1 | NM_003120.3 | c.328C>T | p.Gln110Ter | stop_gained, splice_region_variant | 3/5 | ENST00000378538.8 | |
SPI1 | NM_001080547.2 | c.331C>T | p.Gln111Ter | stop_gained, splice_region_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPI1 | ENST00000378538.8 | c.328C>T | p.Gln110Ter | stop_gained, splice_region_variant | 3/5 | 1 | NM_003120.3 | P4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Agammaglobulinemia 10, autosomal dominant Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 25, 2022 | - - |
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Jun 22, 2022 | This variant is interpreted as pathogenic for Agammaglobulinemia 10, autosomal dominant. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Assumed de novo, but without confirmation of paternity and maternity (PM6); Predicted nullvariant in a gene where LOF is a known mechanism of disease (PVS1 downgraded to strong); Well-established functional studies show a deleterious effect (PS3). - |
PU.1-mutated agammaglobulinemia Pathogenic:1
Pathogenic, no assertion criteria provided | research | Neil Romberg Laboratory, Children's Hospital of Philadelphia | Dec 18, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.